JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2006;59:429-433; doi:10.1136/jcp.2005.029272
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanczuga-Koda, L
Right arrow Articles by Sulkowska, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanczuga-Koda, L
Right arrow Articles by Sulkowska, M
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Breast Cancer

ORIGINAL ARTICLE

Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer

L Kanczuga-Koda, S Sulkowski, A Lenczewski, M Koda, A Wincewicz, M Baltaziak, M Sulkowska

Department of Pathology, Medical University of Bialystok, Poland

Correspondence to:
Professor S Sulkowski
Department of Pathology, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland; sulek{at}zeus.amb.edu.pl Background: Gap junctions are intercellular channels composed of connexins, which mediate the direct passage of small molecules between neighbouring cells. They are involved in regulation of cell cycle, cell signalling, and differentiation, and probably invasion and metastasis. The role of connexins in the metastatic process is controversial, because some studies indicate that connexin expression is inversely correlated with metastatic capacity. In contrast, others demonstrate that connexins may be involved in metastasis. In addition, connexin status in breast cancer metastasis has not been widely studied.

Methods: We evaluated by immunohistochemistry the expression of connexin 26 (Cx26) and connexin 43 (Cx43) in primary breast tumours (PTs) and matched paired metastases to lymph nodes (MLNs).

Results: In PTs, we observed predominantly cytoplasmic localisation of evaluated connexins, indicating alterations in connexin expression in breast cancer cells. We demonstrated that expression of Cx26 and Cx43 was increased in MLNs compared with PTs (p<0.00001 and p<0.001, for CX26 and Cx43, respectively). In addition, Cx26 and Cx43 negative PTs developed Cx26 and Cx43 positive MLNs. Furthermore, besides increased cytoplasmic staining, enhanced membranous localisation of Cx43, typical of normal cells, was found in MLNs. Additionally, membranous Cx26 expression appeared only in metastatic breast cancer cells.

Conclusions: These findings suggest that connexins may contribute to the efficient metastasising of breast cancer to the lymph nodes.


Abbreviations: Cx26, connexin 26; Cx43, connexin 43; GJIC, gap junctional intercellular communication; PT, primary breast tumour; MLN, metastasis to lymph node

Keywords: connexin 26; connexin 43; breast cancer; primary tumour; lymph node metastases




This article has been cited by other articles:


Home page
INT J SURG PATHOLHome page
A. M. Chabowska, M. Sulkowska, A. Chabowski, A. Wincewicz, M. Koda, and S. Sulkowski
Erythropoietin and Erythropoietin Receptor in Colorectal Cancer
International Journal of Surgical Pathology, July 1, 2008; 16(3): 269 - 276.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
K. Ezumi, H. Yamamoto, K. Murata, M. Higashiyama, B. Damdinsuren, Y. Nakamura, N. Kyo, J. Okami, C. Y. Ngan, I. Takemasa, et al.
Aberrant Expression of Connexin 26 Is Associated with Lung Metastasis of Colorectal Cancer
Clin. Cancer Res., February 1, 2008; 14(3): 677 - 684.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.